WL-276, an Antagonist Against BCL-2 Proteins, Overcomes Drug Resistance and Suppresses Prostate Tumor Growth
Cancer Research - United States
doi 10.1158/0008-5472.can-07-6590
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2008
Authors
Publisher
American Association for Cancer Research (AACR)